The United States has achieved a record low death rate, with provisional data from the Centers for Disease Control (CDC) indicating 689.2 deaths per 100,000 people in 2025. This figure represents the lowest level since organized data collection began over 125 years ago, suggesting it is likely the lowest death rate in the nation's 250-year history.
This new age-adjusted rate shows a 4.6 percent decrease from the previous year and is approximately 4 percent below the 2019 pre-pandemic level. These falling mortality rates are projected to drive US life expectancy to a new record high in 2025, following its first-time achievement of 79 years in 2024.
These developments mark a significant turnaround after a decade where US life expectancy stalled and declined. From 2014 to 2021, life expectancy dropped from 78.9 years to 76.4 percent. While the COVID-19 pandemic was a major contributor, rising death rates from drug overdoses, gun homicides, alcohol-related issues, and metabolic diseases predated the pandemic.
Factors Driving Declines
The most significant factor in the recent decline is the dramatic reduction in drug overdose deaths, particularly those involving synthetic opioids like fentanyl. In 2013, synthetic opioid overdose deaths stood at 3,105. By 2023, this number had surged to 72,776, contributing to a peak of 114,000 overdose deaths in the 12 months ending in late 2023. However, by 2025, overdose deaths had fallen to an estimated 70,000, a decrease of nearly 40 percent in two years. Researchers attribute this rapid decline to a combination of increased naloxone distribution, shifts in the illicit fentanyl supply, and the grim reality that many of the most vulnerable drug users have already succumbed.
Overdose deaths disproportionately affect younger populations, meaning their decline has a substantial impact on the national average life expectancy. The death rate for Americans aged 25 to 34 fell by about 16 percent in 2024 and continued to decline in 2025. Concurrently, homicide rates have also decreased significantly, falling by approximately 13 percent in 2023 and 15 percent in 2024, with further declines anticipated in 2025.
Deaths attributed to COVID-19 also saw a substantial drop, decreasing by 37 percent in 2024, moving the virus from the 10th to the 15th leading cause of death. This broad decline extended across all ten leading causes of death in 2024, including heart disease and cancer, indicating a general improvement in mortality across the board.
Long-Term Progress and Future Potential
Historically, American life expectancy has seen dramatic improvements, particularly in the 20th century, largely due to advancements in public health infrastructure such as clean water, sanitation, food safety, childhood immunization, and antibiotics. These measures drastically reduced deaths from infectious diseases like pneumonia, tuberculosis, and diarrheal disease. By the end of the 20th century, these had become rare causes of death in the US.
Progress continues in managing chronic diseases. Cancer death rates have fallen 34 percent since 1991, averting an estimated 4.8 million deaths through reduced smoking, earlier detection, and improved treatments. Deaths from heart attacks have also been declining for decades.
More recently, advancements in medications like GLP-1 agonists, such as Ozempic, are showing promise. These drugs have contributed to a decline in adult obesity rates from a high of 39.9 percent in 2022 to 37 percent in 2025, the first sustained decrease in a generation. Obesity is a significant risk factor for leading causes of death, including heart disease, certain cancers, diabetes, and kidney disease. Clinical trials have also indicated that semaglutide can reduce the risk of heart attack, stroke, and cardiovascular death by 20 percent.
Despite these gains, US life expectancy still lags behind that of comparable wealthy nations by about 3.7 years. This gap is largely attributed to Americans dying at younger ages, with the US death rate under 70 nearly double the average in peer countries. Furthermore, significant disparities persist within the US, with life expectancy varying by as much as eight years between states like Hawaii and West Virginia, and substantial gaps existing based on socioeconomic status and education level.
While challenges such as gun violence, alcohol abuse, and metabolic diseases remain, the recent data suggests a positive trajectory. The potential impact of new medical interventions and the continued progress in public health indicate that further increases in both the length and quality of life are attainable.